首页> 外文期刊>Journal of Biopharmaceutical Statistics >Analysis of Missing Mechanism in IVUS Imaging Clinical Trials with Missing Covariates
【24h】

Analysis of Missing Mechanism in IVUS Imaging Clinical Trials with Missing Covariates

机译:带有协变量缺失的IVUS影像临床试验中缺失机制的分析

获取原文
获取原文并翻译 | 示例
           

摘要

Intravascular ultrasound (IVUS) is a clinical imaging procedure used to assess drug effects on the progression of coronary atherosclerosis in clinical trials. It is an invasive medical procedure of measuring coronary artery atheroma (plaque) volume, and leads to high missing rates (often over 30%). This paper uses an IVUS Phase II clinical trial data to explore the missing mechanism of IVUS endpoint, the percent atheroma volume (PAV). We proposed a moving-window method to examine the relationship between continuous covariates such as lipid endpoint and the probability of missing IVUS values, which provides a general approach for missing mechanism exploration. The moving-window method is more intuitive and provides a fuller picture about the relationship. In the example, some covariates such as lipid measures also have high missing rates after 12 months because of compliance issues probably caused by fatigue of blood drawing. We found that if the method of last observation carried forward (LOCF) is used to impute the lipid endpoints, it leads to biologically unexplainable results. Using the multiple imputation approach for the missing covariates results in a more reasonable conclusion about the IVUS missing mechanism. Age, race, and baseline PAV are identified as key potential contributors to the probability of missing IVUS endpoint. This finding can be used to reduce missing values in future IVUS trials by setting up appropriate inclusion and exclusion criteria at the trial design stages.View full textDownload full textKey WordsIVUS, LOCF, Missing mechanism, Moving-window method, Multiple imputationRelated var addthis_config = { ui_cobrand: "Taylor & Francis Online", services_compact: "citeulike,netvibes,twitter,technorati,delicious,linkedin,facebook,stumbleupon,digg,google,more", pubid: "ra-4dff56cd6bb1830b" }; Add to shortlist Link Permalink http://dx.doi.org/10.1080/10543406.2011.550110
机译:血管内超声(IVUS)是一种临床成像程序,用于在临床试验中评估药物对冠状动脉粥样硬化进展的影响。它是一种测量冠状动脉粥样斑块(斑块)体积的侵入性医疗程序,会导致很高的遗漏率(通常超过30%)。本文使用IVUS II期临床试验数据来探索IVUS终点缺失的机制,即动脉粥样硬化体积百分比(PAV)。我们提出了一种移动窗口方法来检查连续协变量(例如脂质终点)与丢失IVUS值的概率之间的关系,这为丢失机制的探索提供了一种通用方法。移动窗口方法更加直观,并且提供了有关关系的更全面的描述。在该示例中,某些协变量(如脂质测量)在12个月后也由于缺少依从性的问题而导致失血率很高,这可能是由于抽血疲劳引起的。我们发现,如果使用最近一次结转的方法(LOCF)来估算脂质终点,则会导致生物学上无法解释的结果。对缺失的协变量使用多重插补方法可以得出关于IVUS缺失机制的更合理的结论。年龄,种族和基线PAV被确定为IVUS终点缺失概率的关键潜在贡献者。通过在试验设计阶段设置适当的纳入和排除标准,可以将这一发现用于减少将来的IVUS试验中的遗漏值。查看全文下载全文关键字IVUS,LOCF,缺失机制,移动窗口方法,多次插补相关var addthis_config = { ui_cobrand:“ Taylor&Francis Online”,servicescompact:“ citeulike,netvibes,twitter,technorati,delicious,linkedin,facebook,stumbleupon,digg,google,更多”,发布:“ ra-4dff56cd6bb1830b”};添加到候选列表链接永久链接http://dx.doi.org/10.1080/10543406.2011.550110

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号